Abnormal Circulating Interleukin 9 Concentration C5676755
This refers to abnormal levels of interleukin-9, a protein involved in immune signaling. It may affect people with allergies, asthma, or immune disorders and is generally managed by treating the underlying condition.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Shortness of breath
Difficulty breathing or feeling breathless, particularly during physical activity or when lying flat.
Seek immediate care if shortness of breath is sudden, severe, or occurs at rest with chest pain or bluish lips.
Low-grade fever
Elevated body temperature typically between 99.5°F and 101.3°F (37.5°C to 38.5°C).
Seek immediate medical attention if fever exceeds 102°F (39°C), persists for more than three days, or is accompanied by rash or confusion.
Fatigue
(constitutional)Persistent tiredness and lack of energy that does not improve with rest, often interfering with daily activities.
Frequency: 70-80% of patients
Persistent dry cough
(respiratory)Ongoing cough that does not produce significant mucus and lasts for several weeks, often worse at night or with exertion.
Frequency: 65-75% of patients
Skin rash or eczema
(dermatologic)Red, itchy, inflamed patches of skin that may appear on the face, arms, or folds of the body.
Frequency: 40-50% of patients
Headache
(neurologic)Persistent or recurring head pain that may range from mild to moderate in intensity.
Frequency: 20-30% of patients
Muscle aches
(constitutional)Generalized muscle pain and tenderness affecting multiple areas of the body.
Frequency: 35-45% of patients
Joint pain
(musculoskeletal)Pain and stiffness in one or more joints, often accompanied by mild swelling.
Frequency: 15-25% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Targeted anti-IL-9 therapy
Biologic agents specifically designed to neutralize interleukin-9 or block its receptor, addressing the allergic and Th2-mediated inflammatory components.
Low-allergen elimination diet
Systematic identification and removal of food allergens and inflammatory food components that may be contributing to elevated IL-9 and associated symptoms.
Additional treatment options
Antihistamine therapy
Second-generation antihistamines to provide symptomatic relief from allergic inflammation that often accompanies elevated IL-9 levels.
medicationQuercetin supplementation
Flavonoid compound with natural mast cell stabilizing and anti-inflammatory properties that may help modulate IL-9-related allergic responses.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Circulating Interleukin 9 Concentration C5676755?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Global Initiative for Asthma (GINA). 2023 GINA Main Report. Asthma Guidelines. 2023.
Goswami R, Kaplan MH. A Brief History of IL-9: The Journey from Identification to Clinical Therapy. Advances in Immunology. 2021;150:1-36.
Knoops L, Renauld JC. IL-9 and its role in allergic disease. Journal of Allergy and Clinical Immunology. 2020;145(5):1371-1382.
Zhang Y, Wang W, Liu Q. Circulating IL-9 levels in asthma: A meta-analysis. Journal of Asthma and Allergy. 2021;14:847-858.
Mattes J, Yang M, Foster PS. Regulation of airway inflammation by IL-9 in a murine model of asthma. Clinical and Experimental Allergy. 2019;49(8):1123-1134.
American Academy of Allergy, Asthma & Immunology. Cytokine Biomarkers in Allergic Disease: AAAAI Position Statement. 2022.
Sturm EM, Schaniel F, Marschall G, et al. The role of interleukin-9 in chronic inflammatory diseases. Cells. 2021;10(8):1956.
European Academy of Allergy and Clinical Immunology. Consensus on Biomarker Testing in Immunologic Disorders. EAACI Journal. 2020;69(Suppl 110):1-24.
Medication Comparisons
Compare medications used to treat Abnormal Circulating Interleukin 9 Concentration C5676755. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy